Cancer leaves a trait of diminished immune tolerance that protects from Alzheimers disease”.
Más información
| Fecha de publicación: | 2019 |
| Objetivos: | Main goal: To investigate the immune checkpoint status in blood and brain tissue of patients with a history of cancer in the past compared to healthy controls, mild AD patients and patients with a history of cancer who later developed AD (Ca+AD). In two AD |
| Instrumento: | FONDECYT |
| Año de Inicio/Término: | 2019-2023 |
| Financiamiento/Sponsor: | CONICYT |
| Rol del Usuario: | COINVESTIGADOR(A) |
| DOI: |
1190958 |